Holen Sie sich die Stockscreener-App
0.1494
45.39%
-0.2132
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$0.3626
Offen:
$0.1495
24-Stunden-Volumen:
18,891
Relative Volume:
66.00
Marktkapitalisierung:
$N/A
Einnahmen:
$7.33M
Nettoeinkommen (Verlust:
$-21.20M
KGV:
-0.1634
EPS:
-0.9143
Netto-Cashflow:
$-12.68M
1W Leistung:
-45.39%
1M Leistung:
-86.71%
6M Leistung:
-95.33%
1J Leistung:
-96.64%
1-Tages-Spanne:
$0.1305
$0.1495
1-Wochen-Bereich:
$0.1305
$0.1495
52-Wochen-Spanne:
$0.1305
$0.1495
Prophase Labs Inc Stock (PRPH) Company Profile
Firmenname
Prophase Labs Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare PRPH vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.1494 | 0 | 7.33M | -21.20M | -12.68M | -0.9143 |
|
TMO
Thermo Fisher Scientific Inc
|
495.72 | 184.15B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
195.06 | 137.93B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
600.52 | 47.82B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
115.42 | 32.62B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
297.54 | 29.19B | 3.17B | 642.63M | 516.49M | 10.77 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-13 | Herabstufung | Dawson James | Buy → Neutral |
| 2021-01-20 | Eingeleitet | Dawson James | Buy |
Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten
Aug Swings: How correlated is ProPhase Labs Inc to the S P500Earnings Overview Summary & Verified Short-Term Plans - baoquankhu1.vn
Short Covering: What analysts say about ProPhase Labs Inc stockVolume Spike & Long-Term Investment Growth Plans - baoquankhu1.vn
Guidance Update: Whats next for ProPhase Labs Inc stockJuly 2025 Final Week & Precise Buy Zone Identification - baoquankhu1.vn
Will ProPhase Labs Inc outperform the market in YEAR2025 AllTime Highs & Low Risk Entry Point Guides - baoquankhu1.vn
ProPhase Labs Hosts Investor Webinar on Growth Portfolio - TipRanks
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd - The Manila Times
ProPhase Labs Provides Update on COVID-19 Receivables - TradingView
ProPhase Labs (PRPH) Provides Update on COVID-19 Receivables Col - GuruFocus
ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture - ChartMill
ProPhase Labs Secures Funding and Completes Market Transition Following Reverse Stock Split - AD HOC NEWS
ProPhase Labs Announces Uplisting to OTCID Market - TipRanks
ProPhase Labs (PRPH) Uplisted to OTC Market - GuruFocus
Prophase Labs Approves Strategic Proposals at Special Meeting - MSN
ProPhase Labs, Inc.Common Stock (NQ: PRPH - FinancialContent
ProPhase Labs Updates Shareholders Amid Volatility and OTC Move - TipRanks
ProPhase Labs Announces Immediate Resignation of Board Member - TipRanks
ProPhase Labs Announces Board Resignation - TradingView — Track All Markets
Is ProPhase Labs Inc. stock a safe haven asset2025 Pullback Review & Weekly Watchlist of Top Performers - ulpravda.ru
How ProPhase Labs Inc. stock compares to market leadersCEO Change & Low Drawdown Trading Techniques - ulpravda.ru
How strong is ProPhase Labs Inc. stock balance sheetLayoff News & Community Verified Trade Signals - ulpravda.ru
Will ProPhase Labs Inc. stock outperform Nasdaq indexEarnings Overview Report & AI Driven Stock Reports - ulpravda.ru
MSN Money - MSN
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Total liabilities of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Diluted earnings per share (diluted EPS) of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Cash from investing activities of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
ProPhase Labs faces NASDAQ delisting, plans appeal, OTC move - MSN
ProPhase Labs, Inc.(NasdaqCM: PRPH) dropped from S&P TMI Index - marketscreener.com
ProPhase Labs, Inc. Balance Sheet – OTC:PRPH - TradingView — Track All Markets
Free cash flow per share of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Long term debt to total assets ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Net margin % of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Price to cash flow ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Debt to equity ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Enterprise value to EBITDA ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Net current asset value per share of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Total debt per share of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
EBITDA margin % of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Long term debt to total equity ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Operating cash flow per share of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Net income of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
ProPhase Labs, Inc. Statistics – OTC:PRPH - TradingView — Track All Markets
ProPhase Labs, Inc. Income Statement – OTC:PRPH - TradingView — Track All Markets
Price to earnings ratio of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
ProPhase Labs, Inc. Financial Statements – OTC:PRPH - TradingView — Track All Markets
ProPhase Labs, Inc. Earnings and Revenue – OTC:PRPH - TradingView — Track All Markets
ProPhase Labs, Inc. Revenue Breakdown – OTC:PRPH - TradingView — Track All Markets
Basic earnings per share (basic EPS) of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
Free float of ProPhase Labs, Inc. – OTC:PRPH - TradingView — Track All Markets
How one lab swapped $3.3M of debt for shares, jolting its stock price - Stock Titan
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - MSN
Finanzdaten der Prophase Labs Inc-Aktie (PRPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
0.64%
Kapitalisierung:
|
Volumen (24h):